期刊文献+

6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲酸的合成 被引量:2

Synthesis of 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic Acid
在线阅读 下载PDF
导出
摘要 6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲酸是制备新型抗高血压药奈必洛尔的关键中间体。今以4-氟苯酚为起始原料,经酯化、Fries重排、环化、氢化等6个步骤得到目标产物,总收率27%。4-氟苯酚Ⅰ与乙酸酐酯化得4-氟苯基乙酸酯Ⅱ,Ⅱ在AlCl_3催化下Fries重排得4-氟-2-乙酰基苯酚Ⅲ,比从4-氟苯酚的Friedel-Crafts酰化收率更高,二步总收率58%;Ⅲ与酰化试剂乙二酸二乙酯经酯化、环合及碱性水解得到6-氟-4-氧代-4H-1-苯并吡喃-2-甲酸VI,用一种试剂完成了酰化、环化并引入羧基;Ⅵ在乙酸介质中,以10%Pd/C催化加氢得外消旋6-氟-3,4-二氢-2H-1-苯并吡喃-2-甲酸Ⅶ。以上所述的方法具有条件温和、试剂常见易得、易于工业化的优点,并首次给出了关键中间体及目标产物的光谱图,表明产物结构正确。 6-Fluro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid is the key intermediate of Nebivolol, a new antihypertensive agent. The process for the synthesis of its racemics was studied, which involves 6 steps including esterification, rearrangment, acylation, cyclization, hydrolyzation and hydrogenation with an overall yield of 27%. 4-Fluorophenol (Ⅰ) is firstly esterified with acetic anhydride to give 4-fluorophenyl acetate (Ⅱ), which is rearranged in the presence of anhydrous AICI3 to afford 4-fluoro-2-acetyl phenol (Ⅲ) with a higher yield(58%) than that obtained by direct acylation of 4-fiuorophenol. Ⅲis transformed into 6-fiuoro-4-oxo-4H-1-benzopyran-2-car -boxylic acid (Ⅵ) by treatment with diethyloxalate via acylation,cyclization and hydrolyzation, that is to say, the above three reactions finished by using a single agent. The title product, 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid(Ⅶ) was finally obtained from the reduction of VI by hydrogen with 10% Pd/C as catalyst in acetic acid. The process proposed has the potential perspective to be industrialized due to the mild conditions and readily available agents. The spectra of IR and ^1H-NMR of the title compound and its key intermediate were reported to identify the structure of the product.
出处 《高校化学工程学报》 EI CAS CSCD 北大核心 2007年第3期442-447,共6页 Journal of Chemical Engineering of Chinese Universities
关键词 6-氟-3 4-二氢-2H-1-苯并吡喃-2-甲酸 合成 中间体 奈必洛尔 6-fluoro-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid synthesis intermediate Nebivolol
  • 相关文献

参考文献12

  • 1ZHANGQing-shan(张青山) LIAi-ying(李爱英) GUOBing-nan(郭炳南).The progress in research of new antihypertensive,Nebivolol (新型降血压药奈必洛尔研究进展).中国医药工业杂志,2002,12(7):516-520.
  • 2张青山,李爱英.(S,R,R,R)-奈必洛尔合成路线图解GraphicalSyntheticRoutesof(S,R,R,R)-Nebivolol[J].中国医药工业杂志,2003,34(7):366-368. 被引量:8
  • 3Johannes C W,Visser M S,Weatherhead G S et al.Zr-catalyzed kinetic resolution of allylic ethers and Mo-catalyzed chromene formation in synthesis enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-Nebivolol[J].J Am Chem Soc,1998,120(33):8340 -8347.
  • 4Chandrasekhar S,Reddy M V.Enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-Nebivolol[J].Tetrahedron,2000,56 (34):6339-6344.
  • 5Xhonneux R M,Van Lommen G R E.Agents for lowering the blood pressure[P].EP:334429,1989-09-27.
  • 6Kurono M,Miura K.3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid derivative having optical activity and production thereof[P].JP:63230373,1988-09-26.
  • 7Kurono M,Kondo Y.Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof[P].EP:331078,1989-09-06.
  • 8Kurono M,Kondo Y.Hydantoin derivatives for treating complications of diabetes[P].EP:0264586,1988-04-27.
  • 9Kurono M,Bama Y,Unno R et al.Manufacture of optically active (S)-4-oxochroman-2-carboxylic acid derivatives[P].JP:6092956,1994-04-05.
  • 10Koizu M,Saito Y.Preparation of 6-fluoro-4-chromanone-2-carboxylic acid as intermediate for aldose reductase inhibitors[P].JP:2218674,1990-08-31.

二级参考文献16

  • 1王海山,张致平.3-氨基吡咯烷及其N-乙酰物的合成[J].中国医药工业杂志,1995,26(2):86-88. 被引量:4
  • 2Van de Water A, Janssens W, Van Neuten J, et al.Pharmacological and hemodynamie profile of nebivolol, a chemically novel, potent, and selective β1-adrenergic antagonist [J]. J Cardiovasc Pharmacol, 1988, 11(5):552-563.
  • 3Van Lommen GRE, De Bruyn MFL, Schroven MTJ. 2, 2'-Iminobisethanol derivatives [P]. EP:145067, 1985-06-19.(CA 1986,104:5773e).
  • 4Kim MH, Devlin WH, Das SK, et al. Effects of β-adrenergie blocking therapy on left ventricular diastolic relaxation properties in patients with dilated cardiomyopathy[J]. Circulation, 1999, 100(7) : 729-735.
  • 5Mangrella M, Rossi F, Fici F, et al. Pharmacology of nebivolol[J]. Pharmacol Res, 1998, 38(6):419-431.
  • 6Koizumi T, Saito Y. Preparation of 6-fluoro-4-chro-manone-2-carboxylic acid as intermediate for aldose reductase inhibitors [P]. JP: 02218674, 1990-08-31.(CA 1991, 114:122058t).
  • 7Kurono M, Baba Y, Unno R, et al. Manufacture of optically active (S)-4-oxochroman-2-carboxylic acid derivatives[P]. JP:6092956, 1994-04-05. (CA 1994,121 : 157527s).
  • 8Xhonneux RM, Van Lommen GRE. Agents for lowering the blood pressure [P]. EP: 334429, 1989-09-27. (CA 1990, 113:126609a).
  • 9Johannes CW, Visser MS, Weatherhead GS, et al.Zr-catalyzed kinetic resolution of allylic ethers and Mo-catalyzed chromene formation in synthesis.Enantioselective total synthesis of the antihypertensive agent (S, R, R, R)-nebivolol [J]. J Am Chem Soc, 1998,120(33) :8340-8347.
  • 10Barrett AGM, Hamprecht D, Ohkubo M. Dess-Martin periodinane oxidation of alcohols in the presence of stabilized phosphorus ylides: a convenient method for the homologation of alcohols via unstable aldehydes [J]. J Org Chem, 1997, 62(26):9376-9378.

共引文献10

同被引文献30

  • 1张青山,黄小光,李爱英.奈必洛尔中间体的不对称合成[J].北京理工大学学报,2005,25(6):546-550. 被引量:3
  • 2陈鹏,陈钢,张开元,李鹏.盐酸奈必洛尔的合成[J].中国医药工业杂志,2006,37(5):289-292. 被引量:9
  • 3邓勇,邓超等.一种3,4-二氢-4-氧-2H-1-苯并吡喃-2-羧酸的制备方法[P].CN0710049988,2008-02-13.
  • 4Kurono M and Miura K. 3,4-Dihydro-4-oxo-2H-1- benzopyran- 2-carboxylic acid derivative having optical activity and production thereof[P]. JP63230373, 1988-09- 26.
  • 5Xhonneux RM and Van Lolllrnen GRE. Agents for lowering the blood pressure[P]. EP334429, 1989.
  • 6De Cree J, Gecckens H, Leempoels J, Venhaegen H. Drug Dev. Res. 1986, 8, 109.
  • 7Howe R,Rao B S, andeChodnekar M S. J. Med. Chem. 1970, 13(2):169.
  • 8Kurono M,KondoY, Kasugal M, etc. Hydantion Deratives for treating complcations of diabetes[P]. UP5447946, 1995-- 11 -- 5.
  • 9Kurono M and Kondo Y. Process for the preparation of optically active 4-oxo-l-benzopyran -2-carboxylic acid derivatives and intermediates thereof[P]. EP331078,1989. 09.06.
  • 10Kurono M and Kondo Y. Hydantoin derivatives for treating complications of diabetes[P].EP0264586, 1988--04-- 27.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部